Home / PDGFRA Knockout Cell Lines

PDGFRA Knockout Cell Lines

Gene: PDGFRA

Official Full Name: platelet derived growth factor receptor alphaprovided by HGNC

Gene Summary: This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO15275 PDGFRA Knockout cell line (HEK293) Human PDGFRA 1:3~1:6 Negative Online Inquiry

Background

PDGFRA Gene Knockout Cell Lines are scientifically engineered cell models specifically designed to study the functions of the Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) gene. This gene is crucial in the regulation of cell growth, survival, and differentiation, especially in mesenchymal tissues. Through the precise deletion of PDGFRA, these knockout cell lines enable researchers to investigate the downstream effects of PDGF signaling pathways and their role in various pathologies, including cancer and fibrotic diseases.

The key function of PDGFRA Gene Knockout Cell Lines lies in their ability to provide insights into how the absence of this receptor affects cellular behaviors. By utilizing techniques such as CRISPR/Cas9 gene editing, these cell lines deliver a complete and targeted knockout of the PDGFRA gene, allowing scientists to elucidate the consequences of PDGF signaling disruption on cellular mechanisms such as proliferation, apoptosis, and extracellular matrix dynamics. This detailed approach is invaluable for dissecting the molecular underpinnings of diseases associated with aberrant PDGFRA activity.

In the research community and clinical settings, these knockout cell lines are pivotal for drug discovery, biomarker validation, and mechanism-of-action studies. They serve as vital tools for understanding tumor microenvironments, angiogenesis, and tissue repair—factors that are crucial for developing targeted therapies. Their importance is also underscored by their potential use in toxicology studies, where they can elucidate the cellular responses to various compounds in the absence of PDGFRA signaling.

Compared to other gene-manipulated cell lines, PDGFRA Gene Knockout Cell Lines offer specificity and reliability. The targeted nature of the knockout maximizes the validity of experimental results while minimizing the possibility of off-target effects, ensuring that the biological conclusions drawn are accurate and reproducible. Furthermore, these cells can be integrated into high-throughput screening systems, allowing researchers to expedite the identification of novel therapeutic agents.

For researchers and clinicians aiming to advance our understanding of cellular behavior and its implications for human health, PDGFRA Gene Knockout Cell Lines provide an essential platform for exploration. With our company’s expertise in the development of cutting-edge biological models, we are committed to supplying resources that empower scientific innovation and discovery, ensuring that our clients have access to the highest-quality tools for their research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.